Bulletin
Sanofi’s JAK-2 Drug Kaput!
Farewell to Federatnib…we hardly knew ya’
In a stunning and unexpected announcement this morning, Sanofi pulled the plug on clinical trials and filings for its MF JAK-2 inhibitor SAR 302503(federatnib).
Here’s the text:
Leave a Reply